Use of plasma rich in growth factors and regenerating agent matrix for the treatment of corneal diseases

dc.contributor.author	Sánchez Ávila, Ronald Mauricio
dc.contributor.author	Uribe Badillo, E.
dc.contributor.author	Fernández-Vega González, C.
dc.contributor.author	Muruzábal, Francisco
dc.contributor.author	Sen Corcuera, B.
dc.contributor.author	Baamonde Arbaiza, María Begoña
dc.contributor.author	Quirós Fernández, Luis Manuel
dc.contributor.author	Anitua, E.
dc.contributor.author	Merayo Lloves, Jesús
dc.date.accessioned	2022-02-01T08:06:38Z
dc.date.available	2022-02-01T08:06:38Z
dc.date.issued	2021
dc.identifier.citation	Vision (Switzerland), 5(3), (2021); doi:10.3390/vision5030034
dc.identifier.issn	2411-5150
dc.identifier.uri	http://hdl.handle.net/10651/61821
dc.language.iso	eng
dc.relation.ispartof	Vision (Switzerland)
dc.rights	© 2021 Sánchez Ávila et al.
dc.rights	CC Reconocimiento - No Comercial - Sin Obra Derivada 4.0 Internacional
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85110682648&doi=10.3390%2fvision5030034&partnerID=40&md5=67781e8ecfe063cff87fd65dd3520464
dc.title	Use of plasma rich in growth factors and regenerating agent matrix for the treatment of corneal diseases
dc.type	journal article
dc.identifier.doi	10.3390/vision5030034
dc.relation.publisherversion	http://dx.doi.org/10.3390/vision5030034
dc.rights.accessRights	open access
dc.type.hasVersion	VoR

Este ítem está sujeto a una licencia Creative Commons